RenovoRx, Inc. (RNXT)
NASDAQ: RNXT · Real-Time Price · USD
0.840
-0.030 (-3.46%)
At close: Apr 28, 2026, 4:00 PM EDT
0.840
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:04 PM EDT
RenovoRx Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Revenue | 1.12 | 0.04 | - | - | - | |
| Revenue Growth (YoY) | 2511.63% | - | - | - | - | |
| Cost of Revenue | 0.33 | - | - | - | - | |
| Gross Profit | 0.8 | 0.04 | - | - | - | |
| Selling, General & Admin | 7.04 | 4.99 | 5.73 | 5.65 | 2.63 | |
| Research & Development | 5.77 | 6.03 | 5.67 | 4.3 | 3.04 | |
| Operating Expenses | 12.81 | 11.01 | 11.4 | 9.95 | 5.67 | |
| Operating Income | -12.01 | -10.97 | -11.4 | -9.95 | -5.67 | |
| Interest Expense | - | - | - | - | -0.83 | |
| Interest & Investment Income | 0.43 | 0.38 | 0.11 | 0.06 | - | |
| Other Non Operating Income (Expenses) | 0.92 | 1.77 | 1.06 | 0 | 0.12 | |
| EBT Excluding Unusual Items | -10.67 | -8.81 | -10.23 | -9.89 | -6.39 | |
| Other Unusual Items | -0.5 | - | - | - | 0.06 | |
| Pretax Income | -11.17 | -8.81 | -10.23 | -9.89 | -6.32 | |
| Net Income | -11.17 | -8.81 | -10.23 | -9.89 | -6.32 | |
| Net Income to Common | -11.17 | -8.81 | -10.23 | -9.89 | -6.32 | |
| Shares Outstanding (Basic) | 35 | 22 | 10 | 9 | 5 | |
| Shares Outstanding (Diluted) | 35 | 22 | 10 | 9 | 5 | |
| Shares Change (YoY) | 58.65% | 116.42% | 13.69% | 73.50% | 135.64% | |
| EPS (Basic) | -0.32 | -0.40 | -0.99 | -1.09 | -1.21 | |
| EPS (Diluted) | -0.32 | -0.40 | -0.99 | -1.09 | -1.21 | |
| Free Cash Flow | -10.98 | -9.14 | -10.26 | -8.81 | -5.93 | |
| Free Cash Flow Per Share | -0.31 | -0.41 | -1.00 | -0.97 | -1.14 | |
| Gross Margin | 70.88% | 100.00% | - | - | - | |
| Operating Margin | -1069.46% | -25511.63% | - | - | - | |
| Profit Margin | -994.48% | -20497.67% | - | - | - | |
| Free Cash Flow Margin | -977.29% | -21248.84% | - | - | - | |
| EBITDA | -12.01 | - | -11.39 | -9.94 | -5.66 | |
| D&A For EBITDA | 0 | - | 0.01 | 0.01 | 0.01 | |
| EBIT | -12.01 | -10.97 | -11.4 | -9.95 | -5.67 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.